Cargando…
Targeting myeloid-derived suppressor cells for cancer therapy
The emergence and clinical application of immunotherapy is considered a promising breakthrough in cancer treatment. According to the literature, immune checkpoint blockade (ICB) has achieved positive clinical responses in different cancer types, although its clinical efficacy remains limited in some...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610166/ https://www.ncbi.nlm.nih.gov/pubmed/34403220 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0806 |